Adverse reactions to intravenous contrast media (CM) agents are uncommon, although relevant due to the growing number of radiologic examinations that use iodinated contrast agents. We evaluated number and prevalence of adverse contrast reaction using different contrast compound and its natural history in our population, specifically looking to cases of new contrast compound administration was considered clinically necessary.
Salerno, S., Rusignuolo, R., Calafiore, C., Ricceri, V., Vernuccio, F., Lo Re, G., et al. (2015). SAFETY OF REPEATED MDCT WITH CONTRAST COMPOUND IN CASE OF PREVIOUS MILD OR MODERATE ADVERSE REACTION: A SINGLE CENTRE RETROSPECTIVE STUDY.. In ECR 2015 EPOS [10.1594/ecr2015/C-1327].
SAFETY OF REPEATED MDCT WITH CONTRAST COMPOUND IN CASE OF PREVIOUS MILD OR MODERATE ADVERSE REACTION: A SINGLE CENTRE RETROSPECTIVE STUDY.
SALERNO, Sergio;RUSIGNUOLO, Roberta;CALAFIORE, Claudia;RICCERI, Viola Maria;VERNUCCIO, Federica;Lo Re, G.;LA TONA, Giuseppe;LO CASTO, Antonio
2015-01-01
Abstract
Adverse reactions to intravenous contrast media (CM) agents are uncommon, although relevant due to the growing number of radiologic examinations that use iodinated contrast agents. We evaluated number and prevalence of adverse contrast reaction using different contrast compound and its natural history in our population, specifically looking to cases of new contrast compound administration was considered clinically necessary.
| File | Dimensione | Formato | |
|---|---|---|---|
|
ECR2015_C-1327.pdf
accesso aperto
Dimensione
176.88 kB
Formato
Adobe PDF
|
176.88 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
